DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Remoxipride

Remoxipride

  • 2D6 Substrates 2D6 Inhibitors 2D6 Inducers

    2D6 Substrates 2D6 Inhibitors 2D6 Inducers

  • Antipsychotics

    Antipsychotics

  • The Dose-Concentration-Effect Relationships—The Basis for TDM. a Critical Appraisal Lars F

    The Dose-Concentration-Effect Relationships—The Basis for TDM. a Critical Appraisal Lars F

  • Electronic Search Strategies

    Electronic Search Strategies

  • Tardive Akathisia

    Tardive Akathisia

  • Dopamine Receptor Contribution to the Action of PCP, LSD and Ketamine

    Dopamine Receptor Contribution to the Action of PCP, LSD and Ketamine

  • Nervous System Drug Poster

    Nervous System Drug Poster

  • Multi-Discipline Review

    Multi-Discipline Review

  • Medical Review(S)

    Medical Review(S)

  • Download Product Insert (PDF)

    Download Product Insert (PDF)

  • Chlorpromazine Equivalents: a Consensus of Opinion for Both Clinical and Research Applications

    Chlorpromazine Equivalents: a Consensus of Opinion for Both Clinical and Research Applications

  • (2006.01) A61P 25/36 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/US20 19/059852 (22) International Filing Date: 05 November 2019 (05

    (2006.01) A61P 25/36 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/US20 19/059852 (22) International Filing Date: 05 November 2019 (05

  • Typical Versus Atypical Antipsychotics (Caudate-Putamen/Nucleus Accumbens Shell/Extrapyramidal Side Effects/Mrna) KALPANA M

    Typical Versus Atypical Antipsychotics (Caudate-Putamen/Nucleus Accumbens Shell/Extrapyramidal Side Effects/Mrna) KALPANA M

  • And Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated Sven Ove Ogren, Dr.Med.Sc

    And Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated Sven Ove Ogren, Dr.Med.Sc

  • Avoidance of Dopamine-Blocking Medications in Patients with Parkinson's Disease

    Avoidance of Dopamine-Blocking Medications in Patients with Parkinson's Disease

  • Appendix 22B

    Appendix 22B

  • Do Novel Antipsychotics Have Similar Pharmacological Characteristics? a Review of the Evidence J

    Do Novel Antipsychotics Have Similar Pharmacological Characteristics? a Review of the Evidence J

  • Tardive Dyskinesia

    Tardive Dyskinesia

Top View
  • Dose Response and Dose Equivalence of Antipsychotics
  • NIH Public Access Author Manuscript Psychopharmacology (Berl)
  • Downloaded From
  • 'Serotonin and Schizophrenia'
  • Pharmacogenetics of Antidepressants and Antipsychotics
  • ARCI CLASSIFICATION PROGRAM V14.1
  • Antipsychotic Drugs Which Elicit Little Or No Parkinsonism Bind More Loosely
  • A Genome-Wide Positioning Systems Network Algorithm for in Silico Drug Repurposing
  • Dopamine Receptors
  • W O 2019/183564 Al 26 September 2019 (26.09.2019) W IP0I PCT
  • Phenotyping of Drug Metabolism in Infants and Children: Potentials and Problems
  • Prediction of Pka Values for Neutral and Basic Drugs Based on Hybrid
  • The Risk of Hip Fracture After Initiating Antihypertensive Drugs in the Elderly [Published Online November 19, 2012]
  • And D2-Dopaminergic Receptors in the Primate Cerebral Cortex
  • A Meta-Analysis of the Efficacy of Second-Generation Antipsychotics
  • Dose-Response-Time Data Analysis: an Underexploited Trinity
  • The Substituted Benzamides and Their Clinical Potential on Dysthymia and on the Negative Symptoms of Schizophrenia L Pani1 and GL Gessa2
  • Subject Index


© 2024 Docslib.org    Feedback